A Controlled Trial of Mifepristone in Gulf War Veterans With Chronic Multisymptom Illness
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
We propose to conduct placebo-controlled trial of the glucocorticoid receptor antagonist
mifepristone in Gulf War veterans (GWV) with chronic multisymptom illness (CMI) to examine
its effects on physical and mental health and cognitive functioning. In addition, we propose
to examine whether HPA axis biomarkers or their response to mifepristone are useful
predictors of clinical response.
Phase:
Phase 4
Details
Lead Sponsor:
Bronx Veterans Medical Research Foundation, Inc
Collaborators:
U.S. Army Medical Research and Development Command U.S. Army Medical Research and Materiel Command